Astria Learning welcomed a senior delegation from the University of Ibadan (UI), Nigeria’s first and most prestigious university, for a strategic visit focused on exploring how digital campus ...
3hon MSN
Universal, ready-to-use immunotherapy detects and destroys endometrial cancer in preclinical tests
Endometrial cancer is the most common gynecologic cancer in the United States and is one of the few cancers in which survival ...
The Brighterside of News on MSN
Could a hot cup of matcha stop you from sneezing?
Hay fever sufferers have attempted various treatments and techniques. They have tried antihistamines, nasal sprays, air purifiers, and staying indoors when pollen counts are at their highest. The ...
TheraPetic® Healthcare Provider Group, founded by Dr. Patrick Fisher, PhD, NCC, LPC, reports it has served more than ...
Discover how targeted red and near-infrared light therapies influence mitochondrial biology, cellular repair pathways, and emerging clinical treatments across multiple health systems.
Traditional fee-for-service has been predominant despite long-term conversations about value-based care. But the latter model is likely to expand and serve as a more common option alongside ...
Recent research has opened the debate on whether chemical imbalances cause depression, anxiety, and other conditions ...
Head and neck cancer (HNC) represents a significant global health challenge, characterized by aggressive local invasion, frequent recurrence, and poor survival rates. Beyond its physical burden, HNC ...
Clinical trials help address the drivers of high mortality rates; late diagnosis, high treatment costs, under-resourced healthcare systems and limited access to modern cancer therapies.
Japan has approved two stem cell-based therapies for treating Parkinson's disease and heart failure in a world first, through ...
Explore the latest colorectal cancer treatment advances, from precision oncology and immunotherapy to ADCs, bispecifics, and ...
VESALIUS-CV is a large (N=12 257), rigorously conducted, international, randomized, placebo-controlled trial conducted in patients at high cardiovascular risk but without prior myocardial infarction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results